What does the evidence say about Hmb Muscle Soreness Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Hmb Muscle Soreness Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - The Cochrane ROB2 tool and GRADE framework were used to assess the risk of bias and evidence certainty. [Xie C (2026); evidence level 1] - Conclusion Resistance training combined with amino acid supplementation may improve muscle strength and physical function in older adults with sarcopenia, although effects on muscle mass remain limited. [Xie C (2026); evidence level 1] - Background and objective Resistance training is the cornerstone of sarcopenia management. [Xie C (2026); evidence level 1] - However, whether combining it with amino acid-based supplementation, including essential amino acids, branched-chain amino acids, leucine, and derivatives such as HMB, provides additional benefits remains unclear. [Xie C (2026); evidence level 1] - Although supportive evidence is emerging, real-world clinical benefits remain to be substantiated. [Brough L (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.